Clinical Trial Update: Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating XELOX (capecitabine plus oxaliplatin) followed by maintenance capecitabine in advanced gastric cancer; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Stomach Neoplasms | Phase 3 | Status: UNKNOWN